Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom production.
Abstract: Enhancement of antivenom immune responses in horses through adjuvant technology improves antivenom production efficiency, but substantial local reactogenicity associated with some traditional veterinary adjuvants limits their usability. To explore modern adjuvant systems suitable for generating antivenom responses in horses, we first assessed their physicochemical compatibility with Bothrops asper snake venom. Liposome and nanoparticle aluminum adjuvants exhibited changes in particle size and phospholipid content after mixing with venom, whereas squalene emulsion-based adjuvants remained stable. Next, we evaluated serum antibody response magnitude and neutralization capacity in horses immunized with adjuvant-containing Echis ocellatus, Bitis arietans, Naja nigricollis, and Dendroaspis polylepis venom preparations. Whereas all tested adjuvants elicited significant neutralization capacity against the viperid venoms, the greatest antibody responses were generated by a squalene-in-water emulsion, thus representing a promising novel alternative for antivenom production.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Publication Date: 2023-07-24 PubMed ID: 37495191DOI: 10.1016/j.toxicon.2023.107229Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates how modern additives (adjuvants) can boost the immune response in horses to snake venom, which can then be used to produce more effective antivenom. The research found that a specific type of adjuvant, based on squalene, showed the most promise for this purpose.
Background
- Antivenom is a medication made from the blood of animals, like horses, that have been exposed to venom and developed an immune response against it.
- Adjuvants are substances added to vaccines or medications to increase the body’s immune response.
- While some adjuvants can make antivenom production more efficient, they can also cause strong local reactions in horses, limiting their use.
Objective
- The study aimed to identify modern adjuvants that can be used safely in horses to enhance their immune response to snake venom, making antivenom production more efficient.
Methodology
- First, the researchers tested the physical and chemical compatibility of various adjuvants with the venom of the Bothrops asper snake.
- Liposome and nanoparticle aluminum adjuvants showed changes when mixed with the venom, whereas squalene emulsion-based adjuvants remained stable.
- Next, they evaluated the immune response in horses after they were given venom from different snakes mixed with the tested adjuvants.
Results
- All the adjuvants tested were effective in eliciting a significant immune response against viper snake venoms.
- The most robust immune response was observed in horses treated with a squalene-in-water emulsion adjuvant.
Conclusion
- The squalene-in-water emulsion adjuvant appears to be a promising new option for producing antivenom, as it generates a strong immune response without causing harmful reactions in the horses.
Cite This Article
APA
Fox CB, Khandhar AP, Khuu L, Phan T, Kinsey R, Cordero D, Gutiérrez JM, León G.
(2023).
Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom production.
Toxicon, 232, 107229.
https://doi.org/10.1016/j.toxicon.2023.107229 Publication
Researcher Affiliations
- Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: christopher.fox@aahi.org.
- Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
- Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
- Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
- Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
MeSH Terms
- Horses
- Animals
- Antivenins / pharmacology
- Emulsions
- Squalene
- Snake Venoms
- Adjuvants, Immunologic / pharmacology
- Immunization
- Viperidae
Conflict of Interest Statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Authors declare no Competing Non-Financial Interests but the following Competing Financial Interests. CBF and APK are inventors on patents and/or patent applications involving adjuvant formulations and methods featured here. All other authors declare they have no competing interests.